Scarica l'app Stockscreener
1.43
4.74%
0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.37
Aprire:
$1.4
Volume 24 ore:
2.08M
Relative Volume:
0.50
Capitalizzazione di mercato:
$1.13B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-7.5263
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
-0.35%
1M Prestazione:
-20.28%
6M Prestazione:
-1.71%
1 anno Prestazione:
+16.67%
Intervallo 1D:
$1.38
$1.45
Intervallo di 1 settimana:
$1.37
$1.45
Portata 52W:
$1.15
$2.035
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Confronta OPK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.43 | 1.13B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
432.90 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
193.57 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
421.60 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.66 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
142.92 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround - Yahoo Finance
OPKO Health Target of Unusually Large Options Trading (NASDAQ:OPK) - MarketBeat
Altshuler Shaham Ltd Makes New $2.08 Million Investment in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Norges Bank Acquires Shares of 1,127,468 OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Bone Cancer Drugs Market Deep Research 2025-2032 | Advaxis, Inc., Cellectar Biosciences, Inc., OPKO Health, Inc. - openPR.com
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - GlobeNewswire
OPKO Health, Inc. (NASDAQ:OPK) boasts of bullish insider sentiment with 52% ownership and they have been buying lately - Yahoo Finance
Q3 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 125,000 Shares - MarketBeat
OPKO Health (NASDAQ:OPK) Earns "Buy" Rating from HC Wainwright - MarketBeat
Quote - OPKO Health, Inc.
NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program - MarketScreener
Opko Health’s CEO Phillip Frost buys $169,712 in stock - Investing.com Australia
Hypopituitarism Market on Track for Major Expansion by 2032, - openPR.com
Hypopituitarism Market on Track for Major Expansion by 2032, According to DelveInsight | OPKO Health, Lumos Pharma, Versartis Inc., I-Mab Biopharma Co. Ltd - The Globe and Mail
Opko Health's CEO Phillip Frost buys $169,712 in stock By Investing.com - Investing.com Canada
Opko Health’s CEO Phillip Frost buys $169,712 in stock By Investing.com - Investing.com South Africa
Opko Health's CEO Phillip Frost buys $169,712 in stock - Investing.com
Weekly Top Insider Buys Highlight for the Week of April 12 - GuruFocus
Opko health CEO Phillip Frost buys $184,650 in stock By Investing.com - Investing.com India
Opko health CEO Phillip Frost buys $184,650 in stock - Investing.com
H.C. Wainwright maintains $3 target, Buy on Opko Health stock By Investing.com - Investing.com UK
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
OPKO Health authorizes $100 million increase to share buyback program - MSN
OPKO Health Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume After Insider Buying Activity - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Sees Large Increase in Short Interest - MarketBeat
Phillip Md Et Al Frost Buys 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
Iron Mountain, EOG, Oklo, NuScale, Opko: Insider Moves Unveiled - TipRanks
OPKO Health Boosts Stock Buyback Program by $100 Million - marketscreener.com
Opko Health Announces $100 Million Increase To Its Existing Share Repurchase Program - MarketScreener
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewswire
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Global Clinical Laboratory Tests Market Set to Witness - openPR.com
Opko health CEO Phillip Frost buys $164,850 in stock By Investing.com - Investing.com Canada
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opko Health Inc Azioni (OPK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 11 '24 |
Buy |
1.56 |
500,000 |
781,050 |
212,411,477 |
4.80%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):